150 / 464
150
SCIENTIFIC PROGRAMME
| Programme and Exhibition Guide
MONDAY 8 MAY 2017
SYMPOSIUM
Patient Reported Outcomes (PROs) in radiotherapy
16:45 - 17:45 | STOLZ 1-2
Patient Reported Outcomes (PROs) describe any outcome directly reported by
the patient and is a subjective evaluation about disease and its treatment. With
the development of well validated instruments with robust psychometric qualities
these tools provide a useful way of assessing treatment both in routine practice and
in clinical trials. This session critically reviews the differences between reported
morbidity and associations of clinical outcomes such as survival. Furthermore, how
these tools shape evaluation of routine radiotherapy practice, clinical trials. PROs are
therefore critical to understanding the consequences of radiotherapy from a ‘whole-
person’ perspective and the impact of treatment on people’s lives.
Chair: S. Faithfull (UK)
Co-chair: M. Dolezel (Czech Republic)
16:45 > Differences between PRO and clinician reported morbidity and
associations to clinical outcome
Speaker: K. Kirchheiner (Austria)
SP-0518
17:05 > Collecting PROs in clinical practice to assess radiotherapy toxicity and
develop normal tissue complication probability models
Speaker: A. Gilbert (UK)
SP-0519
17:25 > PROs instruments used in clinical trials
Speaker: S. Faithfull (UK)
SP-0520
PROFFERED PAPERS
Oligometastatic disease
16:45 - 17:45 | SCHUBERT
Chair: P. Ost (Belgium)
Chair: B.A. Jereczek-Fossa (Italy)
16:45 > The role of SBRT in oligorecurrent and oligoprogressive prostate cancer:
a multi-institutional study
L. Triggiani (Italy), S. Magrini, A. Bruni, F. Alongi, A. Magli, A. Bonetta,
L. Livi, R. Santoni, P. Borghetti, M. Maddalo, M.D. Rolando, G. Ingrosso,
N. Pasinetti, M. Buglione
OC-0521
16:55 > Extracranial stereotactic Radiotherapy for lymph nodal recurrences: a
dose escalation trial
F. Deodato (Italy), G. Macchia, M. Ferro, M. Ferro, G. Torre, V. Picardi,
M. Nuzzo, S. Cilla, A. Ianiro, G. Tolento, S. Cammelli, F. Romani,